Zhengze
Lu
,
Yang
Long
,
Xingli
Cun
,
Xuhui
Wang
,
Jianping
Li
,
Ling
Mei
,
Yiliang
Yang
,
Man
Li
,
Zhirong
Zhang
and
Qin
He
*
Key Laboratory of Drug Targeting and Drug Delivery Systems, West China School of Pharmacy, Sichuan University, No. 17, Block 3, Southern Renmin Road, Chengdu 610041, China. E-mail: qinhe@scu.edu.cn; Fax: +86-28-85502532; Tel: +86-28-85502532
First published on 13th May 2025
Correction for ‘A size-shrinkable nanoparticle-based combined anti-tumor and anti-inflammatory strategy for enhanced cancer therapy’ by Zhengze Lu et al., Nanoscale, 2018, 10, 9957–9970, https://doi.org/10.1039/C8NR01184B.
The Royal Society of Chemistry apologises for these errors and any consequent inconvenience to authors and readers.
This journal is © The Royal Society of Chemistry 2025 |